PACS Group, Inc.
NYSE:PACSFinancial - Conglomerates
+$0.41 today
- Market cap
- $7.35B
- Beta
- 0.00
- P/E (TTM)
- 23.0
- EPS (TTM)
- $1.55
Volume 0.78M
Average 0.84M
PACS EBITDA Margin
EBITDA as a percentage of revenue.
PACS Group, Inc.NYSE: PACS
EBITDA Margin · Q2 FY2026 · quarter ended Jun 2026
EBITDA Margin widens to 9.2%
EBITDA Margin was 9.2% in Q2 FY2026, up 1.9 pp from a year earlier. On a trailing-twelve-month basis it was 8.6%, up 2.5 pp year over year. Over 3 fiscal years it narrowed by 3.6 pp.
Context
- EBITDA Margin widened in 1 of the last 3 fiscal years.
What to watch
Whether EBITDA Margin reaches the consensus estimate from 4 analysts of 12.2% for the fiscal year ending Dec 2026, up from 6.9% in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterJun 2026
- 9.2%-0.5 pp QoQ
- Last fiscal yearDec 2025
- 6.9%+2.3 pp YoY
- LTMJun 2026
- 8.6%+2.5 pp YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +1.9 pp | +4.3 pp | +2.4 pp |
| 1 year | +2.3 pp | +5.3 pp | +2.9 pp |
| 3 years | -3.6 pp | +6.9 pp | +10.6 pp |
| 5 years | — | — | |
| 10 years | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA Margin history
Percent of revenue · from the income statement
- Latest · FY2025
- 6.9%
- Year-over-year change
- +2.3pp
| Period | Period end | EBITDA Margin | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 6.9% | +2.3pp |
| FY2024 | 2024-12-31 | 4.6% | -2.9pp |
| FY2023 | 2023-12-31 | 7.5% | -3.0pp |
| FY2022 | 2022-12-31 | 10.5% | +2.5pp |
| FY2021 | 2021-12-31 | 8.0% | — |
EBITDA Margin vs competitors
How PACS compares with its peers on the latest reported figures
- PACS's LTM Jun 2026 EBITDA Margin of 8.6% is the 8th highest of the 11 companies compared; the peer median is 13.5%.
- Its year-over-year change of +2.5 pp is the 3rd highest of 11, against a peer median of +0.5 pp.
- Over three fiscal years its change of -3.6 pp compares with a peer median of +3.2 pp.
| Company | Period | LTM level | YoY | 3-year change |
|---|---|---|---|---|
| LTM Mar 2026 | 33.2% | -1.1 pp | +212.5 pp | |
| LTM Jun 2026 | 24.2% | +1.1 pp | +3.6 pp | |
| LTM Mar 2026 | 23.1% | +13.2 pp | +6.6 pp | |
| LTM Jun 2026 | 20.3% | +0.5 pp | -1.4 pp | |
| LTM Sep 2026 | 14.0% | -0.5 pp | -0.2 pp | |
| LTM Sep 2026 | 13.1% | +0.5 pp | +7.7 pp | |
| LTM Jun 2026 | 11.3% | -0.1 pp | -0.7 pp | |
| LTM Jun 2026 | 8.6% | +2.5 pp | -3.6 pp | |
| LTM Jun 2026 | 8.3% | +4.0 pp | +22.2 pp | |
| LTM Mar 2026 | 5.9% | -0.7 pp | +2.7 pp | |
| LTM Mar 2026 | 0.5% | +1.0 pp | -0.9 pp | |
| Peer median (excluding PACS) | 13.5% | +0.5 pp | +3.2 pp | |
Competitors are the stored peer set for PACS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 1.17B | 2.42B | 3.11B | 4.09B | 5.29B |
| Cost of Revenue | 979.22M | 2.02B | 2.66B | 3.3B | 4.13B |
| Gross Profit | 187.35M | 400.68M | 447.07M | 792.64M | 1.16B |
| Gross Margin | 16.1% | 16.5% | 14.4% | 19.4% | 21.9% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 96.83M | 149.01M | 213.66M | 343.81M | 415.07M |
| Operating Expenses | 103.99M | 171.32M | 239.3M | 669.57M | 849.64M |
| Depreciation & Amortization | 7.15M | 22.31M | 25.63M | 40.81M | 55.66M |
| EBITDA | 93.86M | 254.89M | 232.87M | 186.7M | 365.57M |
| EBITDA Margin | 8.0% | 10.5% | 7.5% | 4.6% | 6.9% |
| Operating Income | 83.36M | 229.36M | 207.77M | 123.07M | 309.6M |
| Operating Margin | 7.1% | 9.5% | 6.7% | 3.0% | 5.9% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 5.28M | 25.54M | 49.92M | 44.34M | 28.36M |
| Other Income / Expenses | (1.93M) | (22.32M) | (50.46M) | (21.52M) | (25.15M) |
| Income Before Tax | 81.43M | 207.05M | 157.32M | 101.55M | 284.45M |
| Pre-Tax Margin | 7.0% | 8.5% | 5.1% | 2.5% | 5.4% |
| Income Tax Expense | 33.48M | 56.55M | 44.44M | 46.21M | 92.99M |
| Net Income | 47.95M | 150.5M | 112.87M | 55.76M | 191.54M |
| Net Margin | 4.1% | 6.2% | 3.6% | 1.4% | 3.6% |
| EPS (Basic) | 0.32 | 1.00 | 0.75 | 0.38 | 1.23 |
| EPS (Diluted) | 0.32 | 1.00 | 0.75 | 0.38 | 1.22 |
| Weighted Avg Shares | 150.15M | 150.15M | 150.15M | 146.66M | 156.18M |
| Weighted Avg Shares (Diluted) | 150.15M | 150.15M | 150.15M | 148.57M | 156.7M |
PACS Group, Inc.
NYSE:PACS
Intrinsic Alpha fair value
Locked
Current Price
$46.30
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.